Department of Genetics and Genomics.
Friedman Brain Institute.
J Neurosci. 2020 Feb 5;40(6):1176-1185. doi: 10.1523/JNEUROSCI.0518-19.2019.
Human induced pluripotent stem cells (hiPSCs) have revolutionized research on human diseases, particularly neurodegenerative and psychiatric disorders, making it possible to study mechanisms of disease risk and initiation in otherwise inaccessible patient-specific cells. Today, the integration of CRISPR engineering approaches with hiPSC-based models permits precise isogenic comparisons of human neurons and glia. This review is intended as a guideline for neuroscientists and clinicians interested in translating their research to hiPSC-based studies. It offers state-of-the-art approaches to tackling the challenges that are unique to human disease models, particularly interdonor and intradonor variability, and limitations in neuronal maturity and circuit complexity. Finally, we provide a detailed overview of the immense possibilities the field has to offer, highlighting efficient neural differentiation and induction strategies for the major brain cell types and providing perspective into integrating CRISPR-based methods into study design. The combination of hiPSC-based disease modeling, CRISPR technology, and high-throughput approaches promises to advance our scientific knowledge and accelerate progress in drug discovery. Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids, by Ai Tian, Julien Muffat, and Yun Li.
人类诱导多能干细胞(hiPSCs)彻底改变了人类疾病的研究,特别是神经退行性和精神疾病的研究,使得研究疾病风险和发病机制成为可能,而这些研究在原本无法接触的患者特异性细胞中是不可能进行的。如今,CRISPR 工程方法与基于 hiPSC 的模型的结合,使得对人类神经元和神经胶质细胞进行精确同基因比较成为可能。这篇综述旨在为对将其研究转化为基于 hiPSC 的研究感兴趣的神经科学家和临床医生提供指导。它提供了最新的方法来解决人类疾病模型所特有的挑战,特别是供体间和供体内变异性,以及神经元成熟度和回路复杂性的限制。最后,我们详细介绍了该领域提供的巨大可能性,重点介绍了主要脑细胞类型的高效神经分化和诱导策略,并探讨了将基于 CRISPR 的方法整合到研究设计中的问题。基于 hiPSC 的疾病建模、CRISPR 技术和高通量方法的结合有望推进我们的科学知识,并加速药物发现的进展。《利用 3D 脑类器官研究人类神经发育和疾病》,作者 Ai Tian、Julien Muffat 和 Yun Li。